{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T17:47:27Z","timestamp":1789753647303,"version":"4.0.1"},"reference-count":50,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T00:00:00Z","timestamp":1749600000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Ann Clin Transl Neurol"],"published-print":{"date-parts":[[2025,8]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:sec><jats:title>Objective<\/jats:title><jats:p>Cognitive complaints without objective cognitive impairment in Parkinson's Disease, termed Parkinson's Disease\u2010Subjective Cognitive Decline (PD\u2010SCD), have been associated with cognitive decline. However, its progression is heterogeneous, highlighting the need for improved identification of patients at greater risk for deterioration. This cohort study aims to investigate associations between CSF biomarkers and cognitive decline in PD\u2010SCD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We included patients from the PPMI cohort with PD\u2010SCD, available baseline CSF beta\u2010amyloid<jats:sub>1\u201042<\/jats:sub> (A\u03b2<jats:sub>42<\/jats:sub>) and phosphorylated\u2010tau<jats:sub>181<\/jats:sub> (p\u2010tau<jats:sub>181<\/jats:sub>), and longitudinal Montreal Cognitive Assessment (MoCA).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 80 patients were included, with a mean age of 62.1\u2009years and a median disease duration of 5.6 months at baseline. Five patients were identified with biological AD, who showed a more pronounced decline in MoCA (year 7: <jats:italic>\u03b2<\/jats:italic>\u2009=\u2009\u22124.15, <jats:italic>p<\/jats:italic>\u2009=\u20090.009). After excluding AD patients, linear mixed\u2010effects models (LMEM) demonstrated an association between baseline log\u2010transformed A\u03b2<jats:sub>42<\/jats:sub> and MoCA progression (<jats:italic>\u03b2<\/jats:italic>\u2009=\u20092, <jats:italic>p<\/jats:italic>\u2009=\u20090.004). Based on these data, we created three CSF\u2010based subgroups: <jats:italic>Normal A\u03b2<\/jats:italic><jats:sub><jats:italic>42<\/jats:italic><\/jats:sub> (<jats:italic>n<\/jats:italic>\u2009=\u200950), <jats:italic>Low A\u03b2<\/jats:italic><jats:sub><jats:italic>42<\/jats:italic><\/jats:sub> (<jats:italic>n<\/jats:italic>\u2009=\u200925), and <jats:italic>Biological AD<\/jats:italic> (<jats:italic>n<\/jats:italic>\u2009=\u20095). LMEM predicted greater cognitive decline for <jats:italic>Low A\u03b2<\/jats:italic><jats:sub><jats:italic>42<\/jats:italic><\/jats:sub> versus <jats:italic>Normal A\u03b2<\/jats:italic><jats:sub><jats:italic>42<\/jats:italic><\/jats:sub> (<jats:italic>\u03b2<\/jats:italic>\u2009=\u2009\u22120.161 points\u2010per\u2010year, <jats:italic>p<\/jats:italic>\u2009=\u20090.007), and for <jats:italic>Biological AD<\/jats:italic> versus <jats:italic>Normal A\u03b2<\/jats:italic><jats:sub><jats:italic>42<\/jats:italic><\/jats:sub> (<jats:italic>\u03b2<\/jats:italic>\u2009=\u2009\u22120.390 points\u2010per\u2010year, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). The risk of dementia was increased for <jats:italic>Low A\u03b2<\/jats:italic><jats:sub><jats:italic>42<\/jats:italic><\/jats:sub> (HR\u2009=\u20095.2, <jats:italic>p<\/jats:italic>\u2009=\u20090.029) and <jats:italic>Biological AD<\/jats:italic> subgroups (HR\u2009=\u20097.7, <jats:italic>p<\/jats:italic>\u2009=\u20090.013).<\/jats:p><\/jats:sec><jats:sec><jats:title>Interpretation<\/jats:title><jats:p>In PD\u2010SCD, baseline CSF A\u03b2<jats:sub>42<\/jats:sub> is associated with cognitive progression. Furthermore, we identified three CSF biomarker\u2010based cognitive trajectories (<jats:italic>Normal A\u03b2<\/jats:italic><jats:sub><jats:italic>42<\/jats:italic><\/jats:sub>, <jats:italic>Low A\u03b2<\/jats:italic><jats:sub><jats:italic>42<\/jats:italic><\/jats:sub>, and <jats:italic>Biological AD<\/jats:italic>), each characterized by progressively worse cognitive outcomes. These findings could be useful for implementing enrichment strategies in future clinical trials targeting PD\u2010associated cognitive decline.<\/jats:p><\/jats:sec>","DOI":"10.1002\/acn3.70075","type":"journal-article","created":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T02:40:47Z","timestamp":1749696047000},"page":"1575-1584","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["<scp>CSF<\/scp> Biomarker\u2010Based Cognitive Trajectories in Parkinson's Disease\u2010Subjective Cognitive Decline"],"prefix":"10.1002","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9316-1772","authenticated-orcid":false,"given":"Jon","family":"Rodriguez\u2010Antiguedad","sequence":"first","affiliation":[{"name":"Medicine Department Universitat Aut\u00f2noma de Barcelona (UAB)  Barcelona Spain"},{"name":"Movement Disorders Unit, Neurology Department Hospital de la Santa Creu i Sant Pau  Barcelona Spain"},{"name":"Institut D'investigacions Biom\u00e8diques\u2010Sant Pau (IIB\u2010Sant Pau)  Barcelona Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red\u2010Enfermedades Neurodegenerativas (CIBERNED)  Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8883-4947","authenticated-orcid":false,"given":"Arnau","family":"Puig\u2010Davi","sequence":"additional","affiliation":[{"name":"Medicine Department Universitat Aut\u00f2noma de Barcelona (UAB)  Barcelona Spain"},{"name":"Movement Disorders Unit, Neurology Department Hospital de la Santa Creu i Sant Pau  Barcelona Spain"},{"name":"Institut D'investigacions Biom\u00e8diques\u2010Sant Pau (IIB\u2010Sant Pau)  Barcelona Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red\u2010Enfermedades Neurodegenerativas (CIBERNED)  Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2015-5857","authenticated-orcid":false,"given":"I\u00f1igo","family":"Ru\u00edz\u2010Barrio","sequence":"additional","affiliation":[{"name":"Medicine Department Universitat Aut\u00f2noma de Barcelona (UAB)  Barcelona Spain"},{"name":"Movement Disorders Unit, Neurology Department Hospital de la Santa Creu i Sant Pau  Barcelona Spain"},{"name":"Institut D'investigacions Biom\u00e8diques\u2010Sant Pau (IIB\u2010Sant Pau)  Barcelona Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red\u2010Enfermedades Neurodegenerativas (CIBERNED)  Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Pagonabarraga","sequence":"additional","affiliation":[{"name":"Medicine Department Universitat Aut\u00f2noma de Barcelona (UAB)  Barcelona Spain"},{"name":"Movement Disorders Unit, Neurology Department Hospital de la Santa Creu i Sant Pau  Barcelona Spain"},{"name":"Institut D'investigacions Biom\u00e8diques\u2010Sant Pau (IIB\u2010Sant Pau)  Barcelona Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red\u2010Enfermedades Neurodegenerativas (CIBERNED)  Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"V\u00e1zquez\u2010Oliver","sequence":"additional","affiliation":[{"name":"Movement Disorders Unit, Neurology Department Hospital de la Santa Creu i Sant Pau  Barcelona Spain"},{"name":"Institut D'investigacions Biom\u00e8diques\u2010Sant Pau (IIB\u2010Sant Pau)  Barcelona Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red\u2010Enfermedades Neurodegenerativas (CIBERNED)  Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Horta\u2010Barba","sequence":"additional","affiliation":[{"name":"Medicine Department Universitat Aut\u00f2noma de Barcelona (UAB)  Barcelona Spain"},{"name":"Movement Disorders Unit, Neurology Department Hospital de la Santa Creu i Sant Pau  Barcelona Spain"},{"name":"Institut D'investigacions Biom\u00e8diques\u2010Sant Pau (IIB\u2010Sant Pau)  Barcelona Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red\u2010Enfermedades Neurodegenerativas (CIBERNED)  Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"Kulisevsky","sequence":"additional","affiliation":[{"name":"Medicine Department Universitat Aut\u00f2noma de Barcelona (UAB)  Barcelona Spain"},{"name":"Movement Disorders Unit, Neurology Department Hospital de la Santa Creu i Sant Pau  Barcelona Spain"},{"name":"Institut D'investigacions Biom\u00e8diques\u2010Sant Pau (IIB\u2010Sant Pau)  Barcelona Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red\u2010Enfermedades Neurodegenerativas (CIBERNED)  Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0125-7249","authenticated-orcid":false,"given":"Sa\u00fcl","family":"Mart\u00ednez\u2010Horta","sequence":"additional","affiliation":[{"name":"Medicine Department Universitat Aut\u00f2noma de Barcelona (UAB)  Barcelona Spain"},{"name":"Movement Disorders Unit, Neurology Department Hospital de la Santa Creu i Sant Pau  Barcelona Spain"},{"name":"Institut D'investigacions Biom\u00e8diques\u2010Sant Pau (IIB\u2010Sant Pau)  Barcelona Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red\u2010Enfermedades Neurodegenerativas (CIBERNED)  Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,6,11]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-021-00280-3"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-019-02003-1"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000003634"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/acn3.51461"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.29649"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-024-12808-0"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-024-07607-4"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.23659"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000208033"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181f39a78"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrn3549"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.26191"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1097\/WAD.0b013e31819c5ef4"},{"issue":"10","key":"e_1_2_9_15_1","first-page":"1277","article-title":"Association of Cerebrospinal Fluid \u03b2\u2010Amyloid 1\u201342, T\u2010Tau, P\u2010tau181, and \u03b1\u2010Synuclein Levels With Clinical Features of Drug\u2010Naive Patients With Early Parkinson Disease","volume":"70","author":"Kang J.\u2010H.","year":"2013","journal-title":"JAMA Neurology"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(19)30024-9"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000001098"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2013.600"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2022.05.020"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.28779"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2022.11.013"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.24893"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.sleep.2011.01.015"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.25811"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0257372"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-94345-8"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2018.02.018"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.3233\/JPD-212989"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/0895-4356(95)00048-8"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/ene.15890"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2004.057984"},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awae203"},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-160322"},{"key":"e_1_2_9_34_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2018-318956"},{"key":"e_1_2_9_35_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-017-1821-9"},{"key":"e_1_2_9_36_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awr031"},{"key":"e_1_2_9_37_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.0490-10.2010"},{"key":"e_1_2_9_38_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2100708"},{"key":"e_1_2_9_39_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2212948"},{"key":"e_1_2_9_40_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2010.4"},{"key":"e_1_2_9_41_1","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-170680"},{"key":"e_1_2_9_42_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.27232"},{"key":"e_1_2_9_43_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2015-312690"},{"key":"e_1_2_9_44_1","doi-asserted-by":"publisher","DOI":"10.1001\/archneurol.2012.1608"},{"key":"e_1_2_9_45_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awx118"},{"key":"e_1_2_9_46_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.26071"},{"key":"e_1_2_9_47_1","doi-asserted-by":"publisher","DOI":"10.1111\/ene.13395"},{"key":"e_1_2_9_48_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.27035"},{"key":"e_1_2_9_49_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.22007"},{"key":"e_1_2_9_50_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.27862"},{"key":"e_1_2_9_51_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.29725"}],"container-title":["Annals of Clinical and Translational Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/acn3.70075","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T04:03:12Z","timestamp":1755057792000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/acn3.70075"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,11]]},"references-count":50,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["10.1002\/acn3.70075"],"URL":"https:\/\/doi.org\/10.1002\/acn3.70075","archive":["Portico"],"relation":{},"ISSN":["2328-9503","2328-9503"],"issn-type":[{"value":"2328-9503","type":"print"},{"value":"2328-9503","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,11]]},"assertion":[{"value":"2024-12-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-04-28","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-11","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}